BERNSTEIN GERALD 4
4 · GENEREX BIOTECHNOLOGY CORP · Filed Mar 10, 2010
Insider Transaction Report
Form 4
BERNSTEIN GERALD
VP, Medical Affairs
Transactions
- Disposition to Issuer
Common Stock Purchase Option
2009-10-20−100,000→ 0 totalExercise: $0.61Exp: 2009-12-12→ Common Stock (100,000 underlying) - Award
Common Stock Purchase Option
2009-10-20+100,000→ 100,000 totalExercise: $0.61Exp: 2014-10-26→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Deemed cancellation of option in connection with deemed grant of replacement option.
- [F2]The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on December 13, 2004. The original terms of vesting were not amended.